tinidazole has been researched along with amoxicillin in 141 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.13) | 18.7374 |
| 1990's | 42 (29.79) | 18.2507 |
| 2000's | 60 (42.55) | 29.6817 |
| 2010's | 30 (21.28) | 24.3611 |
| 2020's | 6 (4.26) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bellis, D; Boero, M; Chiandussi, L; Di Napoli, A; Petrino, R | 1 |
| Ainley, C; Altare, F; Ansaldi, N; Holton, J; Oderda, G; Osborn, J; Vaira, D | 1 |
| Desai, HG; Gill, HH; Mehta, PR; Prabhu, SR; Shankaran, K | 1 |
| Desai, HG; Gill, HH; Kalro, RH; Mehta, PR; Murti, PK; Prabhu, SR; Ranganathan, S | 1 |
| Ali, MR; Brown, P; Hamilton, I; Lane, M; Morris, A; Nicholson, G; Samarasinghe, D | 1 |
| Bokemeyer, B; Freise, J; Fritsch, RS; Iserhard, R; Schmidt, FW; Soudah, B; Wagner, S; Weissbrodt, H | 1 |
| Ainley, C; Altare, F; Ansaldi, N; Holton, J; Oderda, G; Vaira, D | 1 |
| Borody, TJ; Carrick, J; Hazell, SL | 1 |
| Dickgiesser, N; Kasper, G | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Bigard, MA; Choné, L; Fléjou, JF; Grignon, Y | 1 |
| Chastang, C; De Korwin, JD; Elouaer-Blanc, L; Guerre, J; Lamouliatte, H; Mégraud, F; Sobhani, I | 1 |
| Lamouliatte, H | 1 |
| Malfertheiner, P | 1 |
| Bruel, H; Dabadie, A; Gambert, C; Jezequel, C; Le Gall, E; Pouedras, P | 1 |
| al Nakib, B; Kalaoui, M; Patric, J; Radhakrishnan, S | 1 |
| Bianchi Porro, G; Lazzaroni, M; Parente, F | 1 |
| Armuzzi, A; Branca, G; Cammarota, G; Montalto, M; Papa, A; Pretolani, S; Renzi, C; Tursi, A; Vecchio, FM; Verzí, A | 1 |
| Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A | 1 |
| Aho, P; Höök-Nikanne, J; Kärkkäinen, P; Kosunen, TU; Salaspuro, M | 1 |
| Bargiggia, S; Bianchi Porro, G; Colombo, E; Maconi, G; Parente, F | 1 |
| Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E | 1 |
| Gabryelewicz, A | 1 |
| Bästlein, E; Bayerdörffer, E; Bolle, KH; Hatz, R; Heldwein, W; Höchter, W; Klann, H; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Ruckdeschel, G; Simon, T; Sommer, A; Stolte, M; Weingart, J | 1 |
| Branca, G; Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Trua, F; Tursi, A; Veneto, G | 1 |
| Dammann, HG | 1 |
| Kawano, S; Murakami, M; Saita, H; Tsuji, S | 1 |
| Bästlein, E; Bayerdörffer, E; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Stolte, M | 1 |
| Axon, TT; Clarke, AH; Drake, IM | 1 |
| Cammarota, G; Cannizzaro, O; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, GM | 1 |
| Delpre, G; Livni, E; Niv, Y | 1 |
| Kooy, A; Thijs, JC; Thijs, WJ; Van der Wouden, EJ; Van Zwet, AA | 1 |
| Abdel-Rahman, SM; Nahata, MC; Robinson, DM | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J | 1 |
| Boixeda de Miquel, D | 1 |
| Alberdi, JM; Beckford, C; Blanco, MA; Carnicero, JA; Casanova, A; Crespo, L; Fernández Velázquez, J; Galán, JL; García Benito, MD; Güemes, C; Pérez Mota, A; Pérez Muñoz, C; Pita, L; Villalgordo, C | 1 |
| Ansaldi, N; Bellis, D; Boero, M; Forni, M; Oderda, G; Ponzetto, A; Vaira, D | 1 |
| Agosti, R; Bocus, P; Caletti, G; Grigioni, WF; Mazzoni, C; Orcioni, GF; Paparo, GF; Poli, L; Sottili, S; Togliani, T; Tucci, A | 1 |
| Fireman, Z; Kopelman, Y; Moshkowitz, M; Segal, A; Sternberg, A | 1 |
| Andriulli, A; Clemente, R; Conoscitore, P; Festa, V; Ghoos, Y; Niro, G; Perri, F; Quitadamo, M; Rutgeerts, P | 1 |
| Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianei, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, A; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Hashimoto, Y | 1 |
| Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G | 1 |
| Anti, M; Armuzzi, A; Branca, G; Candelli, M; Canducci, F; Fadda, G; Fedeli, G; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pastorelli, A; Pola, P; Torre, ES | 1 |
| Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
| Gonlachanvit, S; Kladchareon, N; Kullavanijaya, P; Mahachai, V | 1 |
| Attili, AF; Hassan, C; Lionetti, R; Meddi, P; Rinaldi, V; Ripani, C; Tomaselli, G; Winn, S; Zullo, A | 1 |
| Andrea Grassi, S; Battaglia, F; Benedetti, E; Bottona, E; Caroli, A; Costan-Biedo, F; Dal Bò, N; De Bastiani, R; Di Mario, F; Germanà, B; Leandro, G; Madia, D; Marcon, V; Marin, R; Monica, F; Olivieri, P; Orzes, N; Pilotto, A; Ronzani, G; Saggioro, A; Tafner, G | 1 |
| Arancio, F; Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Gasbarrini, A; Gasbarrini, G; Pirozzi, G; Santarelli, L; Zocco, MA | 1 |
| Akhunov, ED; Farztdinov, KM; Katayev, VA; Kazykhanov, NS; Khusnutdinov, SM; Nijevitch, AA; Sataev, VU | 1 |
| Brullet, E; Calvet, X; Campo, R; Garcia, N; Gené, E | 1 |
| Gopanpallikar, A; Rathi, P; Sawant, P | 1 |
| Bucki, R; Gołebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Changchien, CS; Chen, JJ; Hsu, CC; Hu, TH; Lu, SN | 1 |
| Lucas, M; Palhano, MJ; Ribeiro, JM; Victorino, RM | 1 |
| Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
| De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A | 1 |
| Ahn, DS; Choi, IJ; Choi, KW; Chung, IS; Chung, JM; Hong, WS; Jung, HC; Kim, JH; Lee, SI; Rew, JS; Rhee, JC; Yang, US | 1 |
| De Francesco, V; Faleo, D; Ierardi, E; Margiotta, M; Panella, C | 1 |
| Campo, SM; De Francesco, V; Faleo, D; Fornari, F; Gatta, L; Hassan, C; Ierardi, E; Marinone, G; Menegatti, M; Merla, A; Mete, LS; Miglioli, M; Morini, S; Papadìa, C; Perna, F; Perri, F; Pilati, S; Potì, R; Ricci, C; Rinaldi, V; Savioli, A; Tampieri, A; Vaira, D; Vakil, N; Zullo, A | 1 |
| Anagnostopoulos, GK; Arvanitidis, D; Kostopoulos, P; Margantinis, G; Tsiakos, S | 1 |
| Mikhaleva, EN; Tsimmerman, IaS | 1 |
| Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecien, S; Pajdo, R; Pawlik, M; Pawlik, WW; Ptak, A; Stachura, J | 1 |
| Prónai, L; Tulassay, Z | 1 |
| Dabrowski, A; Kos, M; Stefanek, J; Zinkiewicz, K | 1 |
| De Francesco, V; Hassan, C; Ierardi, E; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R | 1 |
| Marzio, L; Toracchio, S | 1 |
| Herszényi, L | 1 |
| Barone, M; Berloco, P; Burattini, O; De Francesco, V; Di Leo, A; Francavilla, A; Ierardi, E; Marangi, S; Margiotta, M; Minenna, MF; Morini, S; Panella, C; Russo, F; Stoppino, V; Zullo, A | 1 |
| Ahuja, V; Bal, CS; Chaudhary, A; Das, B; Pandey, RM; Sharma, MP | 1 |
| Amoruso, A; De Francesco, V; Della Valle, N; Ierardi, E; Muscatiello, N; Panella, C; Stoppino, V | 1 |
| Amarapurkar, A; Amarapurkar, D; Das, HS; Makesar, M | 1 |
| Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
| Kemona, A; Namiot, DB; Namiot, Z; Stasiewicz, J | 1 |
| De Francesco, V; Della Valle, N; Hassan, C; Ierardi, E; Minenna, MF; Monno, R; Morini, S; Panella, C; Pietrini, L; Stoppino, V; Winn, S; Zullo, A | 1 |
| Cucchiara, S; de'Angelis, GL; Ferzetti, A; Franco, MT; Kuvidi, M; Lerro, P; Marinello, D; Oderda, G; Pensabene, L; Romano, C; Strisciuglio, P | 1 |
| Barros, H; David, L; Lunet, N; Mendes, N; Serpa, J | 1 |
| Górski, J; Jaroszewicz, W; Kemona, A; Markowski, AR; Namiot, DB; Namiot, Z; Stasiewicz, J | 1 |
| Cammarota, G; Candelli, M; Cazzato, IA; Cremonini, F; Finizio, R; Gasbarrini, A; Gasbarrini, G; Nista, EC; Ojetti, V; Pignataro, G; Santoro, M; Zocco, MA | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Bielanski, W; Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecien, S; Mierzwa, M; Pawlik, WW; Stachura, J | 1 |
| Hassan, C; Morini, S; Panarese, A; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Ziemniak, W | 1 |
| Bucki, R; Gotebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Modeo, ME; Tursi, A | 1 |
| Cannaviello, C; De Francesco, V; Efrati, C; Hassan, C; Ierardi, E; Maconi, G; Manes, G; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Shaoul, R; Shehada, S; Srugo, I | 1 |
| Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Chan, YJ; Chang, WH; Chen, CJ; Chen, MJ; Shih, SC; Wang, TE | 1 |
| Aguilar, L; Alou, L; Bascones, A; Giménez, MJ; González, N; Granizo, JJ; Maestre, JR; Manso, F; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Ran, ZH; Shen, J; Tong, JL; Xiao, SD | 1 |
| Di Mario, F; Gatta, L; Leandro, G; Vaira, D; Vakil, N | 1 |
| Chaudhry, AS; Kochhar, R; Kohli, KK | 1 |
| Malfertheiner, P; Moayyedi, P | 1 |
| Aguilar, L; Alió, JJ; Alou, L; Cafini, F; Giménez, MJ; González, N; Manso, F; Prieto, J; Sevillano, D; Torrico, M | 1 |
| Andrei, F; Grasso, E; Lionetti, R; Pallone, F; Paoluzi, OA; Ranaldi, R; Stroppa, I; Tosti, C; Visconti, E | 1 |
| Dutta, U; Kochhar, R; Noor, MT; Sidhu, GS; Singh, K; Udawat, H; Vaiphei, K | 1 |
| Albrecht, P; Kotowska, M; Szajewska, H | 1 |
| Brandimarte, G; Elisei, W; Giorgetti, G; Picchio, M; Tursi, A | 1 |
| Chechoulin, Y; Levi, Z; Niv, Y; Schmilovitz-Weiss, H; Schmiloviz-Weiss, H; Sehayek-Shabbat, V; Shalev, T; Shirin, H; Yishai, R | 1 |
| Compare, D; Federico, A; Gravina, AG; Iovene, MR; Loguercio, C; Marmo, R; Miranda, A; Nardone, G; Pilloni, PA; Ricciardiello, L; Rocco, A; Romano, M | 1 |
| Choi, HS; Chun, HJ; Jeen, YT; Keum, B; Kim, CD; Kim, YS; Lee, HS; Park, SH; Ryu, HS; Seo, YS; Um, SH | 1 |
| Azzolini, F; Bedogni, G; Camellini, L; Cavina, M; Decembrino, F; Di Mario, F; Formisano, D; Iori, V; Sassatelli, R; Sereni, G; Tioli, C | 1 |
| Fakheri, H; Hosseini, V; Maleki, I; Mokhtare, M; Sardarian, H; Taghvaei, T | 1 |
| Bonfrate, L; Castorani, L; D'Ambrosio, P; De Francesco, V; Hassan, C; Portincasa, P; Ruggiero, V; Scaccianoce, G; Vannella, L; Zullo, A | 1 |
| Choksey, A; Nasa, M; Phadke, A; Sawant, P | 1 |
| Chen, M; He, L; Hou, X; Li, Z; Lin, S; Song, Z; Zhang, J; Zhou, L | 1 |
| Jeon, HK; Kim, GH | 1 |
| Ahn, JY; Choi, KD; Choi, KS; Gong, EJ; Jung, HY; Kim, DH; Kim, JH; Lee, GH; Lee, JH; Lim, H; Song, HJ; Yun, SC | 1 |
| Bari, Z; Fakheri, H; Hosseini, V; Maleki, I; Metanat, HA; Taghvaei, T; Valizadeh, SM | 1 |
| Chen, MH; Hou, XH; Li, ZS; Lin, SR; Lu, JJ; Meng, LM; Xue, Y; Yan, XE; Zhang, J; Zhou, LY | 1 |
| Chan, CC; Chien, NH; Hung, CS; Lee, CL; Tu, TC; Wu, CH; Yang, YC | 1 |
| Almeida, N; Branquinho, D; Cabral, JE; Casela, A; Donato, MM; Gregório, C; Tomé, L | 1 |
| Fiorini, G; Gatta, L; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Cai, T; Tang, D; Wang, F; Yao, Y; Yuan, L; Yue, C | 1 |
| Chen, CC; Chen, MJ; Chen, YN; Fang, YJ; Lin, JT; Liou, JM; Wu, MS | 1 |
| Bizzarri, B; De' Angelis, GL; Di Mario, F; Gaiani, F; Iuliano, S; Kayali, S; Leandro, G; Manfredi, M; Minelli, R | 1 |
| Shahbazi, S; Vahdat Shariatpanahi, Z | 1 |
| Amato, A; De Francesco, V; Fiorini, G; Mogavero, G; Monica, F; Portincasa, P; Scaccianoce, G; Urban, F; Vaira, D; Vassallo, R; Zullo, A | 1 |
| Attia, TZ; Derayea, SM; Tsujino, H; Tsutsumi, Y; Uno, T; Yamashita, T | 1 |
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Aung, NM; Cooper, D; Danta, M; Hanson, J; Kyi, MM; Myint, NPST; Sain, K; Waiyan, S; Zaw, TT | 1 |
| Arj, A; Gilassi, H; Madani, M; Razavizadeh, M | 1 |
| Alaa Eddin, K; Alassi, MW; Alhalabi, M; Cheha, K | 1 |
| He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X | 1 |
| Hassib, ST; Mostafa, EA; Sharf, MG; Taha, EA | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
14 review(s) available for tinidazole and amoxicillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Effect of lansoprazole on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Tinidazole | 1993 |
Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.
Topics: Amoxicillin; Bismuth; Cimetidine; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Patient Compliance; Peptic Ulcer; Tinidazole | 1993 |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracyclines; Tinidazole | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Tinidazole | 1997 |
Guidelines for the treatment of Helicobacter pylori in the pediatric population.
Topics: Adolescent; Amoxicillin; Bismuth; Child; Child, Preschool; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Tinidazole | 1997 |
[Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 2003 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome | 2009 |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicable Disease Control; Cytochrome P-450 CYP3A Inhibitors; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea; Tinidazole | 2014 |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole; Treatment Outcome | 2018 |
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
74 trial(s) available for tinidazole and amoxicillin
| Article | Year |
|---|---|
Mono and dual therapy for Helicobacter pylori associated gastritis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Norfloxacin; Organometallic Compounds; Tinidazole | 1991 |
Duodenal ulcer relapse after eradication of Helicobacter pylori.
Topics: Amoxicillin; Antacids; Bismuth; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Prospective Studies; Recurrence; Tinidazole | 1991 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Topics: Adult; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Placebos; Prospective Studies; Recurrence; Tinidazole; Treatment Failure | 1995 |
Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Sucralfate; Tinidazole | 1993 |
Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antitrichomonal Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Penicillins; Stomach Neoplasms; Tinidazole | 1995 |
The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Time Factors; Tinidazole | 1996 |
Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Penicillins; Tinidazole | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1996 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole | 1996 |
Ranitidine in a twice daily triple-therapy regimen for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Tinidazole | 1996 |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Tinidazole | 1996 |
One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Tinidazole | 1997 |
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole | 1997 |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Time Factors; Tinidazole | 1997 |
Family treatment of symptomatic children with Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Carrier State; Child; Child, Preschool; Chronic Disease; Disease Transmission, Infectious; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Family; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Prevalence; Stomach Ulcer; Tinidazole; Treatment Outcome | 1997 |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tinidazole; Treatment Outcome; Urea | 1998 |
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole | 1998 |
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole | 1998 |
[Eradication therapies for Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Tinidazole | 1998 |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea | 2000 |
Efficacy of a multistep strategy for Helicobacter pylori eradication.
Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole; Treatment Failure | 2000 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antitrichomonal Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Thailand; Tinidazole; Treatment Outcome | 2000 |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Stomach Ulcer; Tinidazole; Treatment Outcome | 2000 |
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Recurrence; Tinidazole | 2000 |
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Tinidazole | 2000 |
Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Ranitidine; Tinidazole | 2000 |
Limited usefulness of a seven-day twice-a-day quadruple therapy.
Topics: Adult; Aged; Amoxicillin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Stomach Ulcer; Tinidazole; Treatment Outcome | 2000 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Tinidazole | 2000 |
[The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication].
Topics: Adult; Alcohol Drinking; Amoxicillin; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Smoking; Tinidazole; Treatment Outcome | 2000 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole | 2001 |
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 2001 |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Tinidazole; Treatment Outcome; Urea | 2002 |
High eradication rates of Helicobacter pylori with a new sequential treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Probability; Prospective Studies; Tinidazole; Treatment Outcome | 2003 |
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome | 2003 |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; DNA; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Rabeprazole; Risk Factors; Smoking; Tinidazole; Treatment Outcome | 2004 |
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Lansoprazole; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Time Factors; Tinidazole; Urea | 2004 |
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2004 |
Helicobacter pylori eradication: efficacy of conventional therapy in India.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Tinidazole; Treatment Outcome | 2004 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Smoking; Tinidazole; Treatment Outcome | 2004 |
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Recurrence; Tinidazole; Urea | 2004 |
Lewis and Secretor status and Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Phenotype; Tinidazole; Treatment Outcome; Urea | 2004 |
Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bicarbonates; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Saliva; Tinidazole; Treatment Outcome | 2004 |
Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Aza Compounds; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Moxifloxacin; Patient Compliance; Prospective Studies; Quinolines; Tinidazole; Treatment Outcome | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Tinidazole; Treatment Outcome | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lactobacillus acidophilus; Male; Metronidazole; Middle Aged; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole; Treatment Outcome | 2006 |
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Omeprazole; Oral Hygiene; Peptic Ulcer; Tinidazole; Treatment Outcome | 2007 |
Effect of lactoferrin supplementation on the effectiveness and tolerability of a 7-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole | 2007 |
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Levofloxacin; Male; Middle Aged; Ofloxacin; Rabeprazole; Tinidazole; Treatment Outcome | 2007 |
Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Tinidazole; Treatment Outcome; Young Adult | 2010 |
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Omeprazole; Proton Pump Inhibitors; Tinidazole; Urea | 2011 |
High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole; Treatment Outcome | 2011 |
Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Tinidazole; Treatment Outcome; Young Adult | 2012 |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Rabeprazole; Stomach Ulcer; Tinidazole | 2012 |
Comparison of hybrid and sequential therapies for Helicobacter pylori eradication in Iran: a prospective randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Pantoprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome | 2013 |
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Tinidazole; Urea | 2013 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Pantoprazole; Prospective Studies; Tinidazole; Treatment Outcome | 2013 |
A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; China; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Tinidazole; Treatment Outcome; Young Adult | 2014 |
Comparison Between 10- and 14-Day Hybrid Regimens for Helicobacter pylori Eradication: A Randomized Clinical Trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Pantoprazole; Peptic Ulcer; Tinidazole | 2015 |
Effect of Helicobacter pylori eradication on reflux esophagitis therapy: a multi-center randomized control study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Esomeprazole; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Tinidazole; Young Adult | 2015 |
Comparison between daily single-dose triple therapy and conventional triple therapy on patient compliance and Helicobacter pylori eradication: A randomized controlled trial.
Topics: Adult; Amoxicillin; Clarithromycin; Dysgeusia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Patient Compliance; Tinidazole; Treatment Failure; Treatment Outcome; Young Adult | 2018 |
Sequential therapy for first-line Helicobacter pylori eradication: 10- or 14-day regimen?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Time Factors; Tinidazole; Treatment Outcome | 2019 |
Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
Topics: Amoxicillin; Clarithromycin; Drug Costs; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Myanmar; Rabeprazole; Tinidazole; Treatment Outcome | 2020 |
Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Organometallic Compounds; Tinidazole | 2020 |
Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Esomeprazole; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Syria; Tinidazole; Treatment Outcome; Young Adult | 2021 |
53 other study(ies) available for tinidazole and amoxicillin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Chronic Disease; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Tinidazole | 1992 |
Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Infant; Male; Recurrence; Tinidazole | 1992 |
Dental plaque: a permanent reservoir of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Dental Plaque; Doxycycline; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Organometallic Compounds; Stomach; Tinidazole | 1991 |
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Organometallic Compounds; Prevalence; Salicylates; Tinidazole; Urease | 1990 |
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.
Topics: Administration, Oral; Adolescent; Amoxicillin; Antibodies, Bacterial; Campylobacter; Campylobacter Infections; Child; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrins; Gastritis; Humans; Immunoglobulin G; Male; Nitroimidazoles; Pepsinogens; Pyloric Antrum; Recurrence; Tinidazole | 1989 |
Symptoms improve after the eradication of gastric Campylobacter pyloridis.
Topics: Adult; Aged; Amoxicillin; Campylobacter Infections; Drug Therapy, Combination; Female; Gastritis; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Tinidazole | 1987 |
[Clinical significance, epidemiology and laboratory diagnosis of Campylobacter pyloridis].
Topics: Amoxicillin; Antibodies, Bacterial; Biopsy; Bismuth; Campylobacter; Campylobacter Infections; Chronic Disease; Furazolidone; Gastric Mucosa; Gastritis; Humans; Organometallic Compounds; Tinidazole; Urease | 1986 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Gastritis; Helicobacter; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer; Tinidazole | 1995 |
[Helicobacter pylori gastritis manifested by acute anemia].
Topics: Acute Disease; Amoxicillin; Anemia; Antibodies, Bacterial; Child; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Ranitidine; Tinidazole | 1993 |
Helicobacter pylori-associated gastritis in Kuwait: endoscopy-based study in symptomatic and asymptomatic children.
Topics: Abdominal Pain; Administration, Oral; Adolescent; Amoxicillin; Biopsy; Child; Child, Preschool; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Giardiasis; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Kuwait; Male; Pyloric Antrum; Stomach; Tinidazole | 1993 |
The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Catechols; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Erythromycin; Gastric Mucosa; Helicobacter Infections; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Pentanones; Tetracycline; Tinidazole | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Eruptions; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Tinidazole; Urticaria | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Stomach Ulcer; Time Factors; Tinidazole | 1997 |
Weekend therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tinidazole | 1998 |
Helicobacter pylori and peptic ulcer disease therapies: a survey of gastroenterologists in Israel.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Health Care Surveys; Helicobacter pylori; Humans; Israel; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole | 1998 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole | 2000 |
Remission of a high-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma following Helicobacter pylori eradication and highly active antiretroviral therapy in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; HIV-1; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Remission Induction; Stomach Neoplasms; Tinidazole | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Rabeprazole; Tinidazole | 2002 |
[The state of immune system and effects of current therapy and immunomodulators].
Topics: Adjuvants, Immunologic; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Immunity; Omeprazole; Organometallic Compounds; Tinidazole; Treatment Outcome | 2003 |
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Colony Count, Microbial; Drug Therapy, Combination; Gastric Mucosa; Gastrins; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hyperplasia; Microcirculation; Omeprazole; Penicillins; Radioimmunoassay; Somatostatin; Stomach Ulcer; Tinidazole | 2003 |
[Failure of Helicobacter pylori eradication--suggestions for further therapy].
Topics: Age Distribution; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Metronidazole; Organometallic Compounds; Ranitidine; Rifabutin; Tinidazole; Treatment Failure | 2003 |
Efficacy of the triple therapy: proton pomp inhibitors, amoxicillin and tynidazole in Helicobacter pylori infection treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Middle Aged; Proton Pump Inhibitors; Tinidazole | 2002 |
Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Sex Factors; Tinidazole; Urban Population | 2003 |
Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth; Omeprazole; Saliva; Sex Factors; Stomach; Tinidazole; Treatment Outcome | 2004 |
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; bcl-2-Associated X Protein; Cyclooxygenase 2; Gastric Acid; Gastric Mucosa; Gastrins; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Probiotics; Proto-Oncogene Proteins c-bcl-2; Regional Blood Flow; Somatostatin; Stomach; Stomach Neoplasms; Tinidazole | 2006 |
Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects.
Topics: Adolescent; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tinidazole; Treatment Failure | 2007 |
Endoscopic patterns and histopathological features after eradication therapy in Helicobacter pylori-associated nodular gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Tinidazole; Treatment Outcome | 2008 |
Tinidazole inhibitory and cidal activity against anaerobic periodontal pathogens.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Fusobacterium; Humans; Microbial Sensitivity Tests; Microbial Viability; Periodontal Diseases; Prevotella; Streptococcus; Tinidazole; Veillonella | 2009 |
Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; India; Omeprazole; Phenotype; Polymorphism, Genetic; Tinidazole; Treatment Outcome | 2009 |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
In vitro killing activity of crevicular concentrations of tinidazole plus common oral antibiotics against high-density mixed inocula of periodontal pathogens in strict anaerobic conditions.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Clavulanic Acid; Clindamycin; Drug Synergism; Drug Therapy, Combination; Gingival Crevicular Fluid; Humans; Levofloxacin; Microbial Sensitivity Tests; Microbial Viability; Ofloxacin; Periodontal Diseases; Tinidazole | 2010 |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lansoprazole; Male; Omeprazole; Organometallic Compounds; Tinidazole; Young Adult | 2010 |
Efficacy, tolerability, and factors affecting the efficacy of the sequential therapy in curing Helicobacter pylori infection in clinical setting.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome | 2011 |
Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Comorbidity; Disease Eradication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Ulcer; Young Adult | 2012 |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?
Topics: Amoxicillin; Clarithromycin; Communicable Disease Control; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Republic of Korea; Tinidazole | 2014 |
Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Retrospective Studies; Tinidazole | 2015 |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Portugal; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Young Adult | 2017 |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2018 |
[Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2018 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Incidental Findings; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Tinidazole | 2018 |
Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Omeprazole; Tinidazole | 2019 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach; Stomach Neoplasms; Tinidazole | 2021 |
RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin, and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Naproxen; Omeprazole; Research Design; Tinidazole | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |